JTsui Lab
Integrating AI in
oncology research and
clinical practice
Welcome to the J. Tsui Lab – Where AI Meets Oncology
At the J. Tsui Lab, we are passionate about pushing the boundaries of what AI can do in oncology. From automating treatment planning to working towards personalized radiation therapy, we’re here to make a difference in the lives of patients.
About
James Tsui
BEng, MSc, MDCM, PhD, FRCPC
Dr. James Tsui is a Radiation Oncologist at the MUHC, an Assistant Professor in Clinical Oncology at the McGill University, Associate Member of the Graduate Program in Biological and Biomedical Engineering, and Associate Investigator at the Research Institute.
He completed his Bachelor’s Degree in Electrical Engineering at Concordia University in 2006 and a PhD in computational neuroscience at the Montreal Neurological Institute / McGill University in 2013. He later obtained his MD degree in 2015 and completed his residency training in Radiation Oncology in 2020 at McGill University.
To further his sub-specialization training, he completed a Brachytherapy Fellowship at the Brigham and Women’s Hospital, Harvard, Boston in 2021, and a Professional Master’s Degree in Artificial Intelligence with a focus in Deep Learning at MILA / Université de Montréal in 2023.
His research interests focus on the intersection of machine learning and medicine, with the goal of bringing artificial intelligence into his oncology research and clinical practice.
Areas of Clinical Focus
-
Soft Tissue Sarcoma is a rare type of cancer that arises from connective tissues such as muscle, fat, nerves, and blood vessels. As a provincially designated supraregional sarcoma program, the MUHC sees a high volume of sarcoma cases. We provide comprehensive multidisciplinary care, with treatment typically involving a combination of radiation therapy, chemotherapy, and surgery to ensure the best possible outcomes for our patients.
Find out more here
-
Prostate cancer is one of the most common cancers affecting men, originating in the prostate gland. In addition to standard treatments, we also offer numerous clinical trials to provide patients with access to the latest advancements in care.
Here are two large multi-institutional trials currently enrolling patients.
NRG-GU010: video link
NRG-GU009: video link
-
Gynecologic malignancies include cancers of the uterus, ovaries, cervix, and other reproductive organs. At the MUHC, we provide comprehensive care for women with these cancers, using a multidisciplinary approach that combines surgery, radiation therapy, and chemotherapy.
Find out more here
Current Select Projects
Personalizing Sarcoma Treatment
Our current sarcoma project is focused on integrating AI into the radiation therapy workflow to enhance treatment delivery. In addition, we are also exploring how to safely administer higher doses of radiation to improve tumor control without increasing the risk of side effects.
Find out more here
Project supported by the Cedars Cancer Foundation
Geriatic-oncology Admission Prediction Tool
This project uses machine learning to predict hospital admissions for elderly cancer patients presenting to the emergency room. The goal is to provide a tool that would facilitate early intervention to reduce patients' length of stay in the emergency department and improve overall care efficiency.
Projected supported by the MUHC Foundation
Federated Learning in Radiation Therapy
This project focuses on using a federated approach to develop a deep-learning segmentation tool for lung lesions in Stereotactic Body Radiation Therapy (SBRT). In collaboration with CISSS-CA, we aim to build a model that enhances the precision of treatment while ensuring data privacy by sharing model weights across institutions rather than patient data.
Projected supported by the Cedar Cancer Foundation
Multimodal AI for Bladder Cancer
This project focuses on predicting patient response to concurrent chemoradiation. By integrating various data modalities, we aim to develop an AI model that can accurately predict treatment outcomes, helping to optimize therapeutic decisions for bladder cancer patients.
Projected supported by Dr. Wassim Kassouf lab and by the Montreal General Hospital Foundation
Publications
-
Rahbaran, M, Kalinowski, J, DeCunha, JM, Croce, KD, Bergmark, BA, Tsui, JMG, Devlin, PM, Enger, SA
Medical Physics. 2025. https://doi.org/10.1002/mp.17525
-
Goulet, M, Duguay-Drouin, P, Mascolo-Fortin, J, Mégrourèche, J, Octave, N, Tsui, JMG.
Int J Radiat Oncol Biol Phys. 2025. https://doi.org/10.1016/j.ijrobp.2024.12.026
-
Tsui, JMG, Menard, C.
EchoX 2024. https://issuu.com/otimroepmq/docs/echox_vol45no3_nov_2024_final?fr=xKAE9_zU1NQ
-
Hanafi, H, Freeman, C, Tsui, J, Ramia, P, Turcotte, R, Aoude, A, Bozzo, A, Cury, F.
Practical Radiation Oncology. 2024; https://doi.org/10.1016/j.prro.2024.10.008
-
Yang, D. D.; Lee, K. N.; Lee, L. K.; Tsui, J. M. G.; Leeman, J. E.; McClure, H. M.; Sudhyadhom, A.; Guthier, C. V.; Taplin, M.-E.; Trinh, Q.-D.; Mouw, K. W.; Martin, N. E.; Orio, P. F.; Nguyen, P. L.; D’Amico, A. V.; Shin, K.-Y.; King, M. T.
Radiology. 2024; Vol. 313, No. 1. https://doi.org/10.1148/radiol.240041
-
Akingbade, A; Fabi, F; Cartes, R; Tsui, J; Alfieri, J.
Current Oncology. 2024; 31(7):3758-3770. https://doi.org/10.3390/curroncol31070277.
-
Bozzo, A; Tsui, J; Bhatnagar, S; Forsberg, J.
Journal of the AAOS. 2024; 32(11):e523-e532. https://doi.org/10.5435/JAAOS-D-23-00831.
-
Tsui, J. M. G.; Kehayias, C. E.; Leeman, J. E.; Nguyen, P. L.; Peng, L.; Yang, D. D.; Moningi, S.; Martin, N.; Orio, P. F.; D’Amico, A. V.; Bredfeldt, J. S.; Lee, L. K.; Guthier, C. V.; King, M. T.
International Journal of Radiation Oncology Biology Physics. 2024; 118(1):74-84. https://doi.org/10.1016/j.ijrobp.2023.07.029.
-
Niazi, T.; Nabid, A.; Malagon, T.; Bettahar, R.; Vincent, L.; Martin, A.-G.; Jolicoeur, M.; Yassa, M.; Barkati, M.; Igidbashian, L.; Bahoric, B.; Archambault, R.; Villeneuve, H.; Tsui, J. M. G.; Mohiuddin, M.
International Journal of Radiation Oncology Biology Physics. 2023; 118 (1), 52-62.
-
Rais, F.; Tsui, J. M. G.; Daianska, A.; Faye, M. D.; Lambert, C.; David, M.; Panet-Raymond, V.; Azoulay, M.; Saidi, A.; Hijal, T.
Radiotherapy and Oncology, 2021; 162, 156–161. https://doi.org/10.1016/j.radonc.2021.07.008.
-
Khriguian, J.; Tsui, J. M. G.; Vaughan, R.; Kucharczyk, M. J.; Nabid, A.; Bettahar, R.; Vincent, L.; Martin, A.-G.; Jolicoeur, M.; Yassa, M.; Barkati, M.; Igidbashian, L.; Bahoric, B.; Archambault, R.; Villeneuve, H.; Mohiuddin, M.; Niazi, T.
Journal of Urology, 2021; 205 (6), 1648–1654. https://doi.org/10.1097/JU.0000000000001646.
-
Kucharczyk, M. J.; Tsui, J. M. G.; Khosrow-Khavar, F.; Bahoric, B.; Souhami, L.; Anidjar, M.; Probst, S.; Chaddad, A.; Sargos, P.; Niazi, T.
Frontiers in Oncology, 2020; 10, 312. https://doi.org/10.3389/fonc.2020.00312.
-
Tsui, J. M. G.; Grewal, N. K. S.; Sivapragasam, M.; Flanagan, M.; Golden, D. W.; Alfieri, J.; Mattes, M. D.
International Journal of Radiation Oncology Biology Physics, 2019; 104 (4), 773–777.
-
Fawaz, Z. S.; Kazandjian, S.; Tsui, J. M.; Devic, D. S.; Lecavalier-Barsoum, M.; Vuong, T.; Elakshar, S.; Garant, A.; Lavoie, I.; Niazi, T. M.
Cureus, 2018 10 (7), e2985. https://doi.org/10.7759/cureus.2985
-
Tsui, J. M.; Mihalcioiu, C.; Cury, F. L.
Cureus, 2018 10 (2), e2238. https://doi.org/10.7759/cureus.2238.
-
Tsui, J. M.; Pack, C. C. (2011). Journal of Neurophysiology, 2011; 106(4), 1888-900.
-
Glasser, D. M.; Tsui, J. M.; Pack, C. C.; Tadin, D.
Proceedings of the National Academy of Sciences of the United States of America, 2011; 108(45), E1080-8.
-
Tsui, J. M.; Hunter, J. N.; Born, R. T.; Pack, C. C.
Journal of Neurophysiology, 2010; 103(6), 3123-38. https://doi.org/10.1152/jn.00654.2009.
-
Khawaja, F. A.; Tsui, J. M.; Pack, C. C.
Journal of Neuroscience, 2009; 29(43), 13702-9. https://doi.org/10.1523/JNEUROSCI.2844-09.2009.
-
Churan, J.; Khawaja, F. A.; Tsui, J. M.; Pack, C. C.
Current Biology, 2008; 18(22), R1051-2. https://doi.org/10.1016/j.cub.2008.10.003.